[FURL=https://www.industryarc.com/Research/Lung-Cancer-Screening-Software-Market-Research-508542?utm_source=BriefingWire&utm_medium=PressRelease&utm_campaign=PaidPressRelease]Lung Cancer Screening Software Market[/FURL] size is estimated to reach $45.3 million by 2026, growing at a CAGR of 19.5% during the forecast period 2021-2026. Lung cancer screening is a process of detecting lung cancer with the usage of different technologies and software solutions. Lung cancer screening software helps in the management of patient’s participation in lung screening programs and also provides an efficient way for healthcare professionals to collect, curate, and transfer data to patients. This software also enables to identify cancer patients at risk and automates the flow of data with integrated electronic health records. Increase in the awareness about screening programs, growing number of studies and clinical trials for evaluating the effectiveness of cancer screening software, rise in the demand for screening with chest radiography and low dose computed tomography, and increase in the demand for cloud-based solutions are the factors that are set to drive the growth of the Lung Cancer Screening Software Market for the period 2021-2026.Key Takeaways
Geographically, the North America Lung Cancer Screening Software Market is accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the rise in the demand for screening with chest radiography.
The increase in the demand for innovative technologies in the treatment of non-small cell lung cancer is driving the growth of the Non-small Cell Lung Cancer segment.
Lack of skilled medical personnel is one of the major factors that is said to reduce the growth of the Lung Cancer Screening Software Market.
Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Lung Cancer Screening Software Market report.
Request for Sample of the Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=508542[/FURL]
Lung Cancer Screening Software Market Drivers
Rise in the Demand for Cloud based Solutions
Cloud based Solutions allow oncology centers to leverage a network of remotely accessible servers where they can store large volumes of data in a secure environment.
Increase in the Awareness about the Effectiveness of Lung Cancer Screening Programs
There is a rapid increase in the awareness about lung cancer screening programs owing to the effectiveness in the treatment of lung cancer.
Lung Cancer Screening Software Market top 10 companies are Koninklijke Philips, Siemens Healthineers AG, MRS Systems Inc, Magview, PenRad Technologies Inc, Eon Health, Nuance Communications, ProVation Medical Inc, HealthMyne, Optellum Ltd.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.